AYESHA ASHAI, M.D.
Psychiatry Physician in ERIE, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
AYESHA ASHAI, M.D. reported a CMS MIPS final score of 100/100 — above the 83.1 national average — and filed 608 Medicare Part D claims in 2023.
- 100/100
- MIPS score · +17 vs avg
- 608
- Part D claims, 2023
- 95%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
AYESHA ASHAI, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
100 Top 7% higher than 93% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
AYESHA ASHAI, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about AYESHA ASHAI, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Pennsylvania
How Psychiatry Physician compares to other specialties among Pennsylvania providers
Psychiatry Physician share within Pennsylvania
Psychiatry Physician is one of the more visible NUCC categories in Pennsylvania
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
AYESHA ASHAI, M.D.'s 2023 MIPS final score plotted against the Psychiatry Physician national average
- MIPS Final Score
- 100/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Psychiatry Physician) — 100/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Psychiatry Physician US NPIs
100/100 MIPS final score — 16.9 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Psychiatry Physician. Quality dim: 93.0658.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
AYESHA ASHAI, M.D. appears in the CMS NPPES registry as a Psychiatry Physician provider holding M.D. credentials at 900 STATE ST STE 203B, ERIE, PA, 16501, with a listed phone of (866) 492-7597. NPI 1174866800 was issued on 04/01/2013. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ASHAI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 608 prescription claims written by this provider, covering 32 Medicare beneficiaries and totaling roughly $159K in drug spend, split 5% brand-name and 95% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 93.0658), compared with the national average of 83.1.
Psychiatry Physician is a high-volume specialty nationwide, with 53,104 enrolled providers across 56 states and an average of 1,038 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1174866800 |
|---|---|
| Specialty | Psychiatry Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 04/01/2013 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm AYESHA ASHAI, M.D.'s current license status, disciplinary history, and board certifications with the Pennsylvania State Board of Medicine in Pennsylvania before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
License & disciplinary context — Pennsylvania PA-BOM 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to AYESHA ASHAI, M.D.. To verify AYESHA ASHAI, M.D.'s current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
5% brand-name claims vs 95% generic, on 608 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 792
- Total Day Supply
- 23,130
- Brand vs Generic
- 5% brand / 95% generic
- Brand Drug Cost
- $146K
- Generic Drug Cost
- $13K
Patient Demographics
- Average Patient Age
- 55.5 years
- Avg HCC Risk Score
- 1.55
- Age Distribution
- <65: 19, 65-74: 12, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What AYESHA ASHAI, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Escitalopram Oxalate
Escitalopram Oxalate
90 claims
- Duloxetine Hcl
Duloxetine Hcl
54 claims
- Trazodone Hcl
Trazodone Hcl
44 claims
- Buspirone Hcl
Buspirone Hcl
37 claims
- Lamotrigine 35
Lamotrigine
35 claims
- Quetiapine Fumarate 33
Quetiapine Fumarate
33 claims
- Venlafaxine Hcl Er 32
Venlafaxine Hcl Er
32 claims
- Zolpidem Tartrate 26
Zolpidem Tartrate
26 claims
| Drug | Claims |
|---|---|
| Escitalopram Oxalate | 90 |
| Duloxetine Hcl | 54 |
| Trazodone Hcl | 44 |
| Buspirone Hcl | 37 |
| Lamotrigine | 35 |
| Quetiapine Fumarate | 33 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 32 |
| Zolpidem Tartrate | 26 |
| Hydroxyzine Hcl | 20 |
| Fluoxetine Hcl | 19 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Psychiatry Physician Overview
How AYESHA ASHAI, M.D. fits within the Psychiatry Physician landscape nationally.
AYESHA ASHAI, M.D.'s 608 claims are below the specialty average of 1,038.
Nearby Psychiatry Physician Providers in Pennsylvania
Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as ASHAI.
Compare Psychiatry Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Pennsylvania
Frequently Asked Questions
What is AYESHA ASHAI, M.D.'s specialty? ▼
How much does AYESHA ASHAI, M.D. prescribe under Medicare Part D? ▼
What is AYESHA ASHAI, M.D.'s Medicare quality score? ▼
Where is AYESHA ASHAI, M.D. located? ▼
What is AYESHA ASHAI, M.D.'s NPI number? ▼
Does AYESHA ASHAI, M.D. prescribe more brand-name or generic drugs? ▼
How many Psychiatry Physician providers are there in the US? ▼
What drugs does AYESHA ASHAI, M.D. prescribe most often? ▼
Does AYESHA ASHAI, M.D. accept Medicare? ▼
How can I verify AYESHA ASHAI, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology